Showing results (141-150 of 168) with videos related to

Sort By:
Pageof 17
Journal of Medicinal Chemistry|February 13, 2009
Structure-activity relationships of antitubercular nitroimidazoles. 2. Determinants of aerobic activity and quantitative structure-activity relationshipsPilho Kim, Sunhee Kang, Helena I Boshoff, et al.
ACS Infectious Diseases|June 2, 2026
Cytochrome P450-Mediated Metabolism of Antimycobacterial Nα-Aroyl-N-aryl-phenylalanine AmidesJohannes Doering, Erik Meerz, Rüdiger W Seidel, et al.
Plos One|August 21, 2014
Pharmacokinetics-pharmacodynamics analysis of bicyclic 4-nitroimidazole analogs in a murine model of tuberculosisSuresh B Lakshminarayana, Helena I M Boshoff, Joseph Cherian, et al.
European Journal of Medicinal Chemistry|November 18, 2022
Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit-to-lead optimization and release of a novel antitubercular chemotype via scaffold derivatizationMiriam Girardini, Francesca Ferlenghi, Giannamaria Annunziato, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2019
Phase variation in Mycobacterium tuberculosis glpK produces transiently heritable drug toleranceHassan Safi, Pooja Gopal, Subramanya Lingaraju, et al.
Microbiology Spectrum|November 20, 2023
GaMF1.39's antibiotic efficacy and its enhanced antitubercular activity in combination with clofazimine, Telacebec, ND-011992, or TBAJ-876Priya Ragunathan, Pearly Shuyi Ng, Samsher Singh, et al.
Iscience|July 23, 2025
A potent phenylalkylamine disrupts mycobacterial membrane bioenergetics and augments bactericidal activity of bedaquilineZheng Yen Phua, Ming Li, Azhar Ali, et al.
The Journal of Biological Chemistry|January 4, 2024
High efficacy of the F-ATP synthase inhibitor TBAJ-5307 against nontuberculous mycobacteria in vitro and in vivoPriya Ragunathan, Patcharaporn Sae-Lao, Claire Hamela, et al.
Tuberculosis (Edinburgh, Scotland)|May 10, 2024
Preclinical murine models for the testing of antimicrobials against Mycobacterium abscessus pulmonary infections: Current practices and recommendationsVéronique Dartois, Tracey L Bonfield, Jim P Boyce, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 2008
Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosisMekonnen Kurabachew, Stephen H J Lu, Philipp Krastel, et al.
Pageof 17